Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,022.95
(
0.80%
)
US TECH 100
25,496.00
(
0.00%
)
Dow Jones
48,463.72
(
-0.15%
)
Brent Oil
93.92
(
1.35%
)
Bitcoin
74,567.41
(
-0.35%
)
News Focus
News Focus
Post# of 821515
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor082

Send PM Follow Ignore
Followers 5
Posts 4996
Boards Moderated 1
Alias Born 03/21/2024

Investor082

Re: manibiotech post# 791801

Thursday, 10/09/2025 11:29:38 AM

Thursday, October 09, 2025 11:29:38 AM

Post# of 821515
MHRA already told one or two of the posters recently that they won’t wait for new regulations or frameworks to be finalized. If the data is convincing they will approve.

Just think about this logically. If the data was really convincing in a highly unmet disease, holding off an approval for an efficacious and safe therapy is extremely damaging. No regulatory agency would do that!

Snap out of denial! I wouldn’t trust DennisDave poster. He has been coming up with all kinds of theories to justify the delay.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News